Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Children as young as 13 'with ketamine bladder', says new research

22 September 2026

Sonoco Products: Dividend Aristocrat Value In Plain Sight (NYSE:SON)

22 September 2026

Arm Holdings: The Narrative Can’t Justify The Current Share Price (NASDAQ:ARM)

22 September 2026

Celldex Therapeutics, Inc. (CLDX) Discusses Positive Phase 3 Results for Barzolvolimab in Chronic Spontaneous Urticaria Transcript

22 September 2026

PGIM Quant Solutions International Equity Fund Q2 2026 Commentary

22 September 2026
Facebook X (Twitter) Instagram
Business Tuesday, Sep 22
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » Sonoco Products: Dividend Aristocrat Value In Plain Sight (NYSE:SON)
News

Sonoco Products: Dividend Aristocrat Value In Plain Sight (NYSE:SON)

thebusinesstimes.co.ukBy thebusinesstimes.co.uk22 September 20260 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Share
Facebook Twitter LinkedIn Pinterest Email

This article was written by

I am Gen Alpha. I have more than 16 years of investment experience, and an MBA in Finance. I focus on stocks that are more defensive in nature, with a medium- to long-term horizon. I provide high-yield, dividend growth investment ideas in the investing group iREIT®+HOYA Capital. The group helps investors achieve dependable monthly income, portfolio diversification, and inflation hedging. It provides investment research on REITs, ETFs, closed-end funds, preferreds, and dividend champions across asset classes. It offers income-focused portfolios targeting dividend yields up to 10%. Learn more.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in SON over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I am not an investment advisor. This article is for informational purposes and does not constitute as financial advice. Readers are encouraged and expected to perform due diligence and draw their own conclusions prior to making any investment decisions.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Children as young as 13 'with ketamine bladder', says new research

Arm Holdings: The Narrative Can’t Justify The Current Share Price (NASDAQ:ARM)

Celldex Therapeutics, Inc. (CLDX) Discusses Positive Phase 3 Results for Barzolvolimab in Chronic Spontaneous Urticaria Transcript

PGIM Quant Solutions International Equity Fund Q2 2026 Commentary

Pain of NHS whistleblowers as call for Lucy Letby retrial grows louder

Wealthfront Is Good Value As Further Rate Hikes Loom (NASDAQ:WLTH)

Your Lunch Today Proves What The Fed Can’t Really Fix (NYSEARCA:SPY)

BrainsWay: Execution Isn’t The Problem, Market Size Is (NASDAQ:BWAY)

Pfizer: Stagnant Dividends At Rich Yields – Income Before Appreciation (NYSE:PFE)

Editors Picks

Sonoco Products: Dividend Aristocrat Value In Plain Sight (NYSE:SON)

22 September 2026

Arm Holdings: The Narrative Can’t Justify The Current Share Price (NASDAQ:ARM)

22 September 2026

Celldex Therapeutics, Inc. (CLDX) Discusses Positive Phase 3 Results for Barzolvolimab in Chronic Spontaneous Urticaria Transcript

22 September 2026

PGIM Quant Solutions International Equity Fund Q2 2026 Commentary

22 September 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

Pain of NHS whistleblowers as call for Lucy Letby retrial grows louder

22 September 2026

Wealthfront Is Good Value As Further Rate Hikes Loom (NASDAQ:WLTH)

22 September 2026

Your Lunch Today Proves What The Fed Can’t Really Fix (NYSEARCA:SPY)

22 September 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.